The stock opened at Rs 740.0 in the session so far and touched high and low of Rs 740.0 and Rs 722.0 respectively. Aurobindo Pharma Ltd shares quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 620.55.
At the time of writing this report, Aurobindo Pharma Limited had a total market cap of Rs 42316.49 Crores.
The company reported consolidated sales of Rs 6038.5 crore for the quarter ended 30-Sep-2021, up 4.41 per cent from Rs 5783.29 crore in the previous quarter and 7.63 per cent higher than Rs 6537.19 crore in the year-ago quarter.
Net profit for the latest quarter stood at Rs 696.99 crore, down 13.55 per cent from the same quarter a year ago.
As on 30-September-2021, DII held 9.28 per cent stake in the company, while foreign institutional investors held 23.41 per cent and promoters 51.83 per cent.
According to BSE Data, the stock trades at a price-to-earnings multiplier of 8.11 and a price-to-book ratio of 2.36. A high P/E ratio indicates that investors are willing to pay a higher price due to expectations of better growth in the future. Value-to-book value indicates the inherent value of a company and is a measure of the price that investors are willing to pay even if there is no growth in the business.
Aurobindo Pharma Limited belongs to Pharma – Indian Industry.